---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-006560"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2023-03-06T23:59:59+00:00"
generated_at: "2026-06-18T11:20:35.003384+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Aquestive receives $11.5M payment from Indivior, extends commercial agreement to 2026

## Summary
- Amendment No. 11 extends Commercial Exploitation Agreement with Indivior to August 16, 2026, with automatic one-year renewals.
- Indivior paid $11.482 million, including $5.482M for 2022 and estimated 2023 price increases.
- Amendment revises transfer pricing and payment terms for supplied product.
- Agreement will not auto-renew after last product patent expires; earlier termination rights remain.

## SEC filing metadata
- accession: 0001628280-23-006560
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2023-03-06T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828023006560/0001628280-23-006560-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828023006560/aqst-20230302.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-006560
- JSON: https://secwatch.observer/filing/0001628280-23-006560.json
- Plain text: https://secwatch.observer/filing/0001628280-23-006560.txt

## Key facts
- Material Agreements
  Aquestive Therapeutics, Inc. amended Amendment No. 11 with Indivior Inc. valued at $11,482,000 (effective 2023-03-02).
  - Action: amendment
  - Counterparty: Indivior Inc.
  - Value: $11,482,000
  - Effective: 2023-03-02
  source text: Amendment No. 11 (the “Amendment”) to the Commercial Exploitation Agreement (the “Agreement’), dated as of August 15, 2008, with Indivior Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1398733/000162828023006560/0001628280-23-006560-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.